Chronic HgCl2 treatment increases vasoconstriction induced by electrical field stimulation: Role of adrenergic and nitrergic innervation

Clinical Science

Volumn 121, Issue 8, 2011, Pages 331-341

  Blanco Rivero, Javier ^a,b   Furieri, Lorena B ^a,c   Vassallo, Dalton V ^c   Salaices, Mercedes ^a,c   Balfaǵon, Gloria ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

Electrical field stimulation; HgCl2; Nitric oxide; Noradrenaline; Vascular innervation

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; MERCURIC CHLORIDE; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NORADRENALIN; PHENTOLAMINE; SUPEROXIDE;

ADRENERGIC NERVE; ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; BLOOD VESSEL INNERVATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ELECTROSTIMULATION; INNERVATION; MALE; MESENTERIC ARTERY; NINTRERGIC INNERVATION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPECTROFLUOROMETRY; VASOCONSTRICTION; VASOMOTOR REFLEX; WESTERN BLOTTING;

ACETYLCHOLINE; ANIMALS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROMAGNETIC FIELDS; MALE; MERCURIC CHLORIDE; MESENTERIC ARTERIES; NITRERGIC NEURONS; NITRIC OXIDE; NITROGEN; OXYGEN; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC; VASOCONSTRICTION;

EID: 80052307366     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20110072     Document Type: Article

References (58)

1. Bakir, F., Damluji, S. F., Amin-Zaki, L., Murtadha, M., Khalidi, A., Al-Rawi, N. Y., Tikriti, S., Dhahir, H. I., Clarkson, T.W., Smith, J. C. and Doherty, R. A. (1973) Methylmercury poisoning in Iraq. Science 181, 230-241
2. Aschner, M. and Aschner, J. L. (1990) Mercury neurotoxicity: mechanisms of blood-brain barrier transport. Neurosci. Biobehav. Rev. 14, 169-176
3. Langworth, S., Sallsten, G., Barregard, L., Cynkier, I., Lind, M. L. and Soderman, E. (1997) Exposure to mercury vapor and impact on health in the dental profession in Sweden. J. Dent. Res. 76, 1397-1404
4. Holmes, P., James, K. A. and Levy, L. S. (2009) Is low-level environmental mercury exposure of concern to human health? Sci. Total Environ. 408, 171-182
5. Clarkson, T.W. (1972) The pharmacology of mercury compounds. Annu. Rev. Pharmacol. 12, 375-406
6. Ahammad-Sahib, K. I., Moorthy, K. S., Cameron, J. A. and Desaiah, D. (1988) Isoproterenol potentiation of methyl mercury effects in vivo on cardiac ATPases and 3H-dopamine uptake. Bull. Environ. Contam. Toxicol. 40, 249-254
7. + ATPase in different cerebral fraction in control and intrauterine growth-retarded rats: alterations induced by serotonin. Neurotoxicology 10, 699-706
8. + -ATPase after partial delipidisation with Lubrol. Pharmacol. Toxicol. 60, 184-186
9. Rajanna, B., Chetty, C. S. and Rajanna, S. (1990) Effect of mercury chloride on the kinetics of cationic and substrate activation or the rat brain microsomal ATPase system. Biochem. Pharmacol. 39, 1935-1940
10. Anner, B. M., Moosmayer, M. and Imesch, E. (1992) Mercury blocks the Na-K-ATPase by a ligand-dependent and reversible mechanism. Am. J. Physiol. 262, F830-F836
11. Salonen, J., Seppanen, K., Nyyssonen, K., Korpela, H., Kauhanen, J., Kantola, M., Tuomilehto, J., Esterbauer, H., Tatzber, F. and Salonen, R. (1995) Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation 91, 645-655
12. Houston, M. C. (2007) The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction. Altern. Ther. Health Med. 13, 128-133
13. Virtanen, J. K., Rissanen, T. H., Voutilainen, S and Tuomainen, TP (2007) Mercury as a risk factor for cardiovascular diseases. J. Nutr. Biochem. 18, 75-85
14. Vassallo, D. V., Moreira, C. M., Oliveira, E. M., Bertollo, D. M. and Veloso, T. C. (1999) Effects of mercury on the isolated heart muscle are prevented by DTT and cysteine. Toxicol. Appl. Pharmacol. 156, 113-118
15. Moreira, C. M., Oliveira, E. M., Bonan, C. D., Sarkis, J. J. and Vassallo, D. V. (2003) Effects of mercury on myosin ATPase in the ventricular myocardium of the rat. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 135, 269-275
16. Carmignani, M., Boscolo, P., Artese, L., Del Rosso, G., Porcelli, G., Felaco, M., Volpe, A. R. and Giuliano, G. (1992) Renal mechanisms in the cardiovascular effects of chronic exposure to inorganic mercury in rats. Br. J. Ind. Med. 49, 226-232
17. Huang, Y. L., Cheng, S. L. and Lin, T. H. (1996) Lipid peroxidation in rats administrated with mercuric chloride. Biol. Trace Elem. Res. 52, 193-206
18. Wolf, M. B. and Baynes, J.W (2007) Cadmium and mercury cause an oxidative stress-induced endothelial dysfunction. Biometals 20, 73-81
19. Wiggers, G. A., Peçanha, F. M., Briones, A. M., Pérez-Girón, J.V., Miguel, M., Vassallo, D. V., Cachofeiro, V., Alonso, M. J. and Salaices, M. (2008) Low mercury concentrations cause oxidative stress and endothelial dysfunction in conductance and resistance arteries. Am. J. Physiol. Heart Circ. Physiol. 295, H1033-H1043
20. Stacey, N. H. and Kappus, H. (1982) Cellular toxicity and lipid peroxidation in response to mercury. Toxicol. Appl. Pharmacol. 63, 29-35
21. Gstraunthaler, G., Pfaller, W. and Kotanko, P. (1983) Glutathione depletion and in vitro lipid peroxidation in mercury or maleate induced acute renal failure. Biochem. Pharmacol. 32, 2969-2972
22. Mahboob, M., Shireen, K. F., Atkinson, A. and Khan, A. T. (2001) Lipid peroxidation and antioxidant enzyme activity in different organs of mice exposed to low level of mercury. J. Environ. Sci. Health B 36, 687-697
23. Guo, T. L., Miller, M. A., Shapiro, I. M. and Shenker, B. J. (1998) Mercuric chloride induces apoptosis in human T lymphocytes: evidence of mitochondrial dysfunction. Toxicol. Appl. Pharmacol. 153, 250-257
24. Golpon, H. A., Püchner, A., Barth, P.,Welte, T.,Wichert, P. and Feddersen, C. O. (2003) Nitric oxide-dependent vasorelaxation and endothelial cell damage caused by mercury chloride. Toxicology 192, 179-188
25. Wiggers, G. A., Stefanon, I., Padilha, A. S., Peçanha, F. M., Vassallo, D. V. and Oliveira, E. M. (2008) Low nanomolar concentration of mercury chloride increases vascular reactivity to phenylephrine and local angiotensin production in rats. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 147, 252-260
26. Loesch, A. (2002) Perivascular nerves and vascular endothelium: recent advances. Histol. Histopathol. 17, 591-597
27. Sastre, E., Márquez-Rodas, I., Blanco-Rivero, J. and Balfagón, G. (2010) Perivascular innervation of the superior mesenteric artery: pathophysiological implications. Rev. Neurol. 50, 727-737
28. Balfagón, G., Márquez-Rodas, I., Alvarez, Y., Alonso, M. J., Cachofeiro, V., Salaices, M. and Lahera, V. (2004) Aldosterone modulates neural vasomotor response in hypertension: role of calcitonin gene-related peptide. Regul. Pept. 120, 253-260
29. del Campo, L., Ferrer, M. and Balfagón, G. (2009) Hypertension alters the function of nitrergic and sensory innervation in mesenteric arteries from female rats. J. Hypertens. 27, 791-799
30. Ferrer, M., Marín, J. and Balfag ón, G. (2000) Diabetes alters neuronal nitric oxide release from rat mesenteric arteries. Role of protein kinase C. Life Sci. 66, 337-345
31. Marín, J. and Balfagón, G. (1998) Effect of clenbuterol on non-endothelial nitric oxide release in rat mesenteric arteries and the involvement of β-adrenoceptors. Br. J. Pharmacol. 124, 473-478
32. Ralevic, V., Karoon, P. and Burnstock, G. (1995) Long-term sensory denervation by neonatal capsaicin treatment augments sympathetic neurotransmission in rat mesenteric arteries by increasing levels of norepinephrine and selectively enhancing postjunctional action. J. Pharmacol. Exp. Ther. 274, 64-71
33. Gass ó, S., Sũ nol, C., Sanfeliu, C., Rodríguez-Farré, E. and Cristófol, R. M. (2000) Pharmacological characterization of the effects of methylmercury and mercuric chloride on spontaneous noradrenaline release from rat hippocampal slices. Life Sci. 67, 1219-1231
34. Faro, L. R., Rodrigues, K. J., Santana, M. B., Vidal, L., Alfonso, M. and Durán, R. (2007) Comparative effects of organic and inorganic mercury on in vivo dopamine release in freely moving rats. Braz. J. Med. Biol. Res. 40, 1361-1365
35. Blanco-Rivero, J., Cachofeiro, V., Lahera, V., Aras-Lopez, R., Márquez-Rodas, I., Salaices, M., Xavier, F. E., Ferrer, M. and Balfagón, G. (2005) Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats. Hypertension 46, 107-112
36. Nielsen, K. C. and Owman, C. (1971) Contractile response and amine receptor mechanisms in isolated middle cerebral artery of the cat. Brain Res. 27, 33-42
37. Di Giusto, G. and Torres, A. M. (2010) Organic anion transporter 5 renal expression and urinary excretion in rats exposed to mercuric chloride: a potential biomarker of mercury-induced nephropathy. Arch. Toxicol. 84, 741-749
38. Rice, D. C. (2004) The US EPA reference dose for methylmercury: sources of uncertainty. Environ. Res. 95, 406-413
39. Stern, A. H. (2005) A revised probabilistic estimate of the maternal methyl mercury intake dose corresponding to a measured cord blood mercury concentration. Environ. Health Perspect. 113, 155-163
40. Gupta, M., Bansal, J. K. and Khanna, C. M. (1996) Blood mercury in workers exposed to the preparation of mercury cadmium telluride layers on cadmium telluride base. Ind. Health 34, 421-425
41. Chen, C., Qu, L., Li, B., Xing, L., Jia, G., Wang, T., Gao, Y., Zhang, P., Li, M., Chen, W. and Chai, Z. (2005) Increased oxidative DNA damage, as assessed by urinary 8-hydroxy-2-deoxyguanosine concentrations, and serum redox status in persons exposed to mercury. Clin. Chem. 51, 759-767
42. McKelvey, W., Gwyn, R. C., Jeffry, N., Kass, D., Thorpe, L. E., Garg, R. K., Palmer, C. D. and Parsons, P. J. (2007) A biomonitoring study of lead, cadmium, and mercury in the blood of New York city adults. Envirom. Health Perspect. 115, 1435-1441
43. Furieri, L. B., Galán, M., Avendaño, M. S., García-Redondo, A. B., Aguado, A., Martínez, S., Cachofeiro, V., Bartolomé, M. V., Alonso, M. J., Vassallo, D. V. and Salaices, M. (2011) Endothelial dysfunction of rat coronary arteries after exposure to low concentrations of mercury is dependent on reactive oxygen species. Br. J. Pharmacol. 162, 1819-1831
44. Li, Y. J. and Duckles, S. P. (1992) Effect of endothelium on the actions of sympathetic and sensory nerves in the perfused rat mesentery. Eur. J. Pharmacol. 210, 23-30
45. Kawasaki, H., Takasaki, K., Saito, A. and Goto, K. (1988) Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature 335, 164-167
46. Boeckxstaens, G. E. and Pelckmans, P. A. (1997) Nitric oxide and the non-adrenergic non-cholinergic neurotransmission. Comp. Biochem. Physiol. A Physiol. 118, 925-937
47. Marín, J., Ferrer, M. and Balfagon, G. (2000) Role of protein kinase C in electrical-stimulation-induced neuronal nitric oxide release in mesenteric arteries from hypertensive rats. Clin. Sci. 99, 277-283
48. Ferrer, M., Sánchez, M., Minoves, N., Salaices, M. and Balfagón, G. (2003) Aging increases neuronal nitric oxide release and superoxide anion generation in mesenteric arteries from spontaneously hypertensive rats. J. Vasc. Res. 40, 509-519
49. Lakshmana, M. K., Desiraju, T. and Raju, T. R. (1993) Mercuric chloride-induced alterations of levels of noradrenaline, dopamine, serotonin and acetylcholine esterase activity in different regions of rat brain during postnatal development. Arch. Toxicol. 67, 422-427
50. 3H]norepinephrine by rat brain synaptosomes. Toxicol. Lett. 27, 7-14
51. 3HgCl) injury on nitric oxide synthase (NOS) activity in cultured human umbilical vascular endothelial cells. Toxicology 103, 1-7
52. Blanco-Rivero, J., de las Heras, N., Martín-Fernández, B., Cachofeiro, V., Lahera, V. and Balfagón, G. (2011) Rosuvastatin restored adrenergic and nitrergic function in mesenteric arteries from obese rats. Br. J. Pharmacol. 162, 271-285
53. Xavier, F. E., Salaices, M., Márquez-Rodas, I., Alonso, M. J., Rossoni, L. V., Vassallo, D. V. and Balfagón, G. (2004) Neurogenic nitric oxide release increases in mesenteric arteries from ouabain hypertensive rats. J. Hypertens. 22, 949-957
54. Donald, J. A. and Broughton, B. R. (2005) Nitric oxide control of lower vertebrate blood vessels by vasomotor nerves. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 142, 188-197
55. Piech, A., Dessy, C., Havaux, X., Feron, O. and Balligand, J. L. (2003) Differential regulation of nitric oxide synthases and their allosteric regulators in heart and vessels of hypertensive rats. Cardiovasc. Res. 57, 456-467
56. Aras-López, R., Xavier, F. E., Ferrer, M. and Balfagón, G. (2009) Dexamethasone decreases neuronal nitric oxide release in mesenteric arteries from hypertensive rats through decreased protein kinase C activation. Clin. Sci. 117, 305-312
57. Briones, A. M., Alonso, M. J., Hernanz, R., Miguel, M. and Salaices, M. (2002) Alterations of the nitric oxide pathway in cerebral arteries from spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 39, 378-388
58. Frisbee, J. C., Maier, K. G. and Stepp, D.W. (2002) Oxidant stress-induced increase in myogenic activation of skeletal muscle resistance arteries in obese Zucker rats. Am. J. Physiol. Heart Circ. Physiol. 283, H2160-H2168